1. Whole blood exchange-lymphoplasmapheresis combined transfusion as an immunotherapy in systemic lupus erythematosus

   Zhang Z, Zhao J, Pei S · iScience · 2026 Jul 17

   PubMed 42389606 DOI
2. Protein homeostasis disruption in cisplatin-induced skeletal muscle atrophy: toxicological insights from experimental studies

   Sakai H, Kon R, Ikarashi N · The Journal of toxicological sciences · 2026

   PubMed 42386543 DOI
3. Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor

   Eyre TA, Song Y, Hermine O · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026 Jul 1

   PubMed 42385124 DOI
4. The efficacy of angiogenesis inhibitors combined with chemotherapy in advanced breast cancer: a systematic review and meta-analysis

   Wu J, Li H, Wei L · Frontiers in oncology · 2026

   PubMed 42376666 DOI
5. Concurrent Mantle Cell Lymphoma and Paraneoplastic Membranous Nephropathy

   Lv D, Sun P, Li Y · Kidney medicine · 2026 Jul

   PubMed 42375693 DOI
6. Brucellosis associated with acute kidney injury and pancytopenia: a case report and review of the literature

   Wang Y, Yu F, Wang W · Frontiers in medicine · 2026

   PubMed 42369142 DOI
7. Tislelizumab-induced distal renal tubular acidosis presenting with life-threatening hypokalemia: a case report

   Xu J, Qin L, Wang P · Frontiers in immunology · 2026

   PubMed 42367811 DOI
8. Renal Dysfunction Complicating the Management of Hematologic Diseases

   Zhou S, Yu J, Feng W · European journal of haematology · 2026 Jun 28

   PubMed 42366105 DOI
9. Sulforaphane attenuates cisplatin‑induced acute kidney injury by inhibiting oxidative stress, inflammation and apoptosis via regulation of NRF2

   Wu Z, Lu M, Xu L · Molecular medicine reports · 2026 Aug

   PubMed 42359648 DOI
10. When Rapid Response Becomes Catastrophic: Tumor Lysis Syndrome Following Cisplatin-Etoposide Therapy in Extensive-Stage Small Cell Lung Cancer

    Cruz Figueroa NA, Martinez Arroyo G, Martinez Ruiz G · Cureus · 2026 May

    PubMed 42359180 DOI
11. Rethinking Onconephrology: A Nephro-Nutritional Integrated Approach in Patients with Chronic Kidney Disease and Urological Malignancies

    Trevisani F, Angioi A, Monti A · Nutrients · 2026 Jun 9

    PubMed 42356252 DOI
12. Cardiovascular and Renal Risk Stratification in Patients Referred to an Onconephrology Clinic and Undergoing Different Oncology Therapies: A Real-World Study

    Lai S, Perrotta AM, Pintus G · Biomedicines · 2026 Jun 13

    PubMed 42351770 DOI
13. Bacterial Ghosts as Innovative Transport Vehicles for Platinum-Based Anticancer Drugs

    Pashkunova-Martic I, Klose MHM, Kudela P · ChemMedChem · 2026 Jun 26

    PubMed 42350154 DOI
14. The Nephroprotective Effects of Nebivolol Against Cyclophosphamide-Induced Toxicity Occur via Antioxidant and Anti-Inflammatory Pathways

    Silva AO, de Freitas JMR, Carvalho CM · Journal of biochemical and molecular toxicology · 2026 Jul

    PubMed 42345548 DOI
15. A Case of Concurrent Autoimmune Thyroiditis and Adrenal Insufficiency Following Nivolumab Therapy for Advanced Renal Cell Carcinoma

    Dooley GD, Li H, Agomuoh I · Cureus · 2026 May

    PubMed 42344811 DOI
16. Re: Circulating Kidney Injury Molecule-1 (KIM-1) and Association with Outcome to Adjuvant Immunotherapy in Renal Cell Carcinoma

    Flippot R, Roca L, Calabrese M · European urology · 2026 Jun 24

    PubMed 42342548 DOI
17. Complexed rifampicin with iron mitigates doxorubicin-induced nephrotoxicity

    Basal OA, Saad EA, El Sadda RR · BMC pharmacology & toxicology · 2026 Jun 23

    PubMed 42337768 DOI
18. SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL

    Crombie JL, Ahn IE, Ren Y · Blood advances · 2026 Jun 23

    PubMed 42335220 DOI
19. When Cure Meets Susceptibility: APOL1-Associated Kidney Injury After Gene Therapy for Sickle Cell Disease

    Gartstein E, McNaughton L, Bignall ONR · American journal of hematology · 2026 Jun 21

    PubMed 42324706 DOI
20. Mechanistic evidence for PI3K/Akt-driven reactivation of Nrf2/HO-1 by dapagliflozin in acute cisplatin hepatotoxicity

    El-Ezz DA, Ibrahim NE, Fouad MK · The Journal of pharmacy and pharmacology · 2026 Jun 2

    PubMed 42323899 DOI
21. Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis

    Strohbehn GW, Tokaz MC, Shin DS · JCO oncology practice · 2026 Jun 18

    PubMed 42314089 DOI
22. Severe renal toxicity following adjuvant envafolimab in a patient with ultra-hypermutated (POLE) stage II colorectal cancer: a case report

    Gao Z, Zhang C, Fang Z · AME case reports · 2026

    PubMed 42299417 DOI
23. Paraneoplastic Pemphigus Mimicking Stevens-Johnson Syndrome in a Patient with Multiple Myeloma: A Rare and Clinically Challenging Presentation

    Keshavarz Z, Zangooie A, Sadooghi Rad E · International journal of hematology-oncology and stem cell research · 2026 Jan 1

    PubMed 42293237 DOI
24. Management of Acute Myeloid Leukemia in a Dialysis-Dependent Patient: A Case Report, Literature Review, and Therapeutic Considerations

    Sapkota S, Alshaikhli A, Shah N · Cureus · 2026 Jun

    PubMed 42292729 DOI
25. Unilateral Purtscher-Like Retinopathy Following Gemcitabine and Bevacizumab Therapy for Recurrent Cervical Carcinoma: A Case Report

    Kumar M, Narula R, Kandula P · Cureus · 2026 May

    PubMed 42291884 DOI
26. Immune-Mediated IgA Nephropathy Induced by PD-1 Blockade in Extranodal NK/T-Cell Lymphoma

    Mohammadi N, Li F, Wang H · International medical case reports journal · 2026

    PubMed 42291801 DOI
27. Renal magnesium wasting and functional hypoparathyroidism: a diagnostic and therapeutic challenge in hypocalcemia

    Schlegel A · Laboratory medicine · 2026 Jun 10

    PubMed 42290042 DOI
28. Licochalcone A protects against cisplatin-induced acute kidney injury via the modulation of Nrf2/Keap1-mediated ferroptosis and apoptosis

    Li C, Yang H, Chen M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026 Aug

    PubMed 42287813 DOI
29. Corrigendum to "Evaluating alternative protocols for preventing cisplatin-induced acute kidney injury during hyperthermic intraperitoneal chemotherapy in ovarian cancer" [Volume 208, May 2026, Pages 85-90]

    Lee J, Seo K, Kim J · Gynecologic oncology · 2026 Jun 13

    PubMed 42287765 DOI
30. Biclonal gammopathy with coexistent proximal tubulopathy and cast nephropathy in multiple myeloma: a rare case report

    Yu S, Sun J, Mei X · BMC nephrology · 2026 Jun 12

    PubMed 42286530 DOI
31. Anlotinib combined with neoadjuvant chemotherapy for HR+/HER2- breast cancer (ACNTBC): a prospective, single-arm, single-center phase II clinical study with real-world validation

    Ding J, Meng H, Wang Y · Signal transduction and targeted therapy · 2026 Jun 12

    PubMed 42285923 DOI
32. Prospective Trial on Tolerability and Efficacy of Adjuvant Nedaplatin Plus Docetaxel for Non-Small Cell Lung Cancer

    Teramoto K, Kaku R, Igarashi T · Cancer science · 2026 Jun 12

    PubMed 42285905 DOI
33. Gemcitabine-sirolimus synergy associated thrombotic microangiopathy in a renal transplant recipient with mesenteric leiomyosarcoma: A case report

    Motla V, Baig U, Mulloy L · World journal of transplantation · 2026 Jun 18

    PubMed 42281866 DOI
34. Severe Metabolic Decompensation in Metastatic Sarcomatoid Renal Cell Carcinoma During Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review

    Ciumărnean L, Gerdanovics CA, Orășan OH · Diagnostics (Basel, Switzerland) · 2026 May 29

    PubMed 42279547 DOI
35. Butyric Acid-Modified m-P14 Peptide Ameliorates Anti-Glomerular Basement Membrane Disease

    Jiang N, Gu YL, Kuang H · International journal of molecular sciences · 2026 May 27

    PubMed 42278340 DOI
36. A case series of patients with head and neck cancer undergoing curative-intent chemoradiation receiving low dose transdermal buprenorphine for pain

    Dyer K, Feingold-Link M, Guyer D · Annals of palliative medicine · 2026 May

    PubMed 42273813 DOI
37. B7-1 and PD-L1 crosstalk in podocyte injury: from molecular mechanisms to novel therapeutic strategies for nephrotic syndrome

    Zhang X, Wu C · International urology and nephrology · 2026 Jun 10

    PubMed 42268531 DOI
38. FOLFOX plus nivolumab combination therapy for cisplatin-unfit patients with untreated advanced esophageal squamous cell carcinoma

    Ogura N, Yamamoto S, Morita R · Esophagus : official journal of the Japan Esophageal Society · 2026 Jun 10

    PubMed 42265434 DOI
39. Reversible podocytopathy in a patient with blastoid-variant mantle cell lymphoma: A case of paraneoplastic FSGS and a literature review

    Veiga C, Damásio I, Milheiro J · Nefrologia · 2026 Jun-Jul

    PubMed 42264686 DOI
40. Post-extracorporeal Membrane Oxygenation (ECMO) Bilateral Urolithiasis in an Adolescent With B-cell Acute Lymphoblastic Leukemia (ALL): A Case Report

    Tobia González SG, Raju GA, Smith-Harrison LI · Cureus · 2026 May

    PubMed 42261493 DOI
41. Acute Respiratory and Renal Failure Following Delayed Recognition of T-cell Lymphoblastic Leukemia in a Previously Healthy Child

    Kaufman OR, Ahmad CM, Haberman S · Cureus · 2026 May

    PubMed 42255804 DOI
42. Assessing the hepatic and renal parameters of breast cancer patient blood samples before and after chemotherapy

    Heilat GB, Alwidyan T, Alrosan AZ · Toxicology reports · 2026 Jun

    PubMed 42255660 DOI
43. Light chain deposition disease masquerading as hypophosphatemic osteomalacia: a case report

    Chen J, Bing Q, Liu M · Frontiers in medicine · 2026

    PubMed 42254393 DOI
44. TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer

    Van Damme M, Elzo-Kraemer X, Deman A · Acta clinica Belgica · 2026 Jun 6

    PubMed 42251484 DOI
45. Dual-ligand-modified cantharidin nanoparticles for the treatment of hepatocellular carcinoma via the inhibition of Ephb4

    Jiang W, Zheng H, Wang S · Drug delivery · 2026 Dec 31

    PubMed 42249613 DOI
46. Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways

    Abu-Risha SE, Sokar SS, Mousa MA · Scientific reports · 2026 Jun 4

    PubMed 42243346 DOI
47. QT monitoring in chemotherapy

    Kim PY, Ostos Mendoza KC, Kim JH · Frontiers in cardiovascular medicine · 2026

    PubMed 42238267 DOI
48. Loss of KLF15 expression characterizes proximal tubule injury in cisplatin-induced acute kidney injury: A multi-omics study

    Chen L, Xie S, Yang H · Current research in toxicology · 2026

    PubMed 42238184 DOI
49. Formononetin alleviated cisplatin-induced acute kidney injury by orchestrating renal tubular cell ferroptosis via PI3K/AKT/NRF2 pathway

    Li X, Yan J, Xu Y · Frontiers in pharmacology · 2026

    PubMed 42232189 DOI
50. Long-term complete remission and minimal side effects after CD19/CD22 CAR-T cell cocktail therapy in a living donor with DLBCL: A rare case report

    Zhang Q, Wu J, Meng F · Cell transplantation · 2026 Jan-Dec

    PubMed 42231134 DOI
51. Clinical Characteristics and Outcomes of Immune Checkpoint Inhibitor Associated Renal Toxicities: A Retrospective Pan-Cancer Cohort Study

    Trivedi C, Contini J, Adams M · Clinical therapeutics · 2026 Jun 2

    PubMed 42230259 DOI
52. Effects of argipressin on intraoperative fluid administration in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC): study protocol of a randomised clinical trial (HiPress Trial)

    van Zwol J, Aalbers AGJ, van den Brom CE · BMJ open · 2026 Jun 2

    PubMed 42229964 DOI
53. Head and neck NUT carcinoma-radiotherapy dose, chemotherapy choice, and outcomes: lessons from a 7-year complete remission

    Schulz L, Zähringer M, Kahl KH · Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026 Jun 1

    PubMed 42223602 DOI
54. Efficacy of high-dose chemotherapy combined with hematopoietic stem cell transplantation in advanced neuroblastoma

    Wang L, Gao J, Shu B · Frontiers in oncology · 2026

    PubMed 42222419 DOI
55. Outcomes of critically ill patients with newly diagnosed Burkitt's lymphoma: a monocentric retrospective study

    Cammarota F, Degoutte C, Calvet L · Annals of intensive care · 2026

    PubMed 42221799 DOI
56. Attenuating chemotherapy-induced nephrotoxicity while potentiating antitumor efficacy by transforming a Janus drug into dual-targeting carbonized polymer dots

    Zou W, Shang C, Hao Z · Biomaterials · 2026 May 28

    PubMed 42218108 DOI
57. Extreme hyperleukocytosis and blueberry muffin skin lesions as the initial presentation of neonatal leukemia: a case report

    Bustamante-Ordoñez MA, Macavilca-Toribio MA, Arenas-Vasquez JR · BMC pediatrics · 2026 May 29

    PubMed 42215936 DOI
58. Cyclosporine in hematological disorders: mechanisms, clinical practice and emerging advances

    Tan Z, Hu J, Ye B · Annals of hematology · 2026 May 29

    PubMed 42215807 DOI
59. Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review

    Chiloiro S, De Sanctis SA, Parente B · Reviews in endocrine & metabolic disorders · 2026 May 30

    PubMed 42215784 DOI
60. Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study

    Li R, Li X, Zhu X · Journal of autoimmunity · 2026 Jun

    PubMed 42214214 DOI

Article metadata via PubMed / NLM. This automated feed surfaces recent literature by search query — inclusion is not endorsement, and titles are not screened for clinical relevance. Medical-education content only — not medical advice.